Skip to content

Facial Muscle Exercises vs Fractional Microneedling Radiofrequency for Facial Rejuvenation

Fractional Microneedling Radiofrequency Versus Facial Muscle Exercises for Facial Rejuvenation: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07285577
Enrollment
40
Registered
2025-12-16
Start date
2023-04-01
Completion date
2024-06-10
Last updated
2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Aging

Keywords

Facial rejuvenation, Fractional microneedling radiofrequency, Face yoga, Facial muscle exercises, Non-surgical facelift, Radiofrequency, Wrinkle reduction, Skin texture improvement

Brief summary

This randomized controlled trial compared the effectiveness and safety of fractional microneedling radiofrequency (FMR) and facial muscle exercises (FME) for facial rejuvenation in females with mild to moderate facial aging. Forty participants aged 32-65 were randomized to either an 8-week FME program or three FMR sessions at 4-week intervals. Outcomes included modified quantitative comprehensive grading scale of aging (MQCGS), wrinkle severity rating scale (WSRS), physician global aesthetic improvement score (PGAI), subject global aesthetic improvement score (SGAIS), and patient satisfaction. Primary endpoints were treatment success (≥25% improvement in PGAI) and patient satisfaction at Day 90. Secondary outcomes assessed changes in aging scores, wrinkle severity, and improvement type (lifting versus texture effects). Ethics approval was obtained from the Research Ethics Committee, Faculty of Medicine, Cairo University.

Detailed description

Facial aging involves changes in skin texture, loss of volume, and tissue descent. Fractional microneedling radiofrequency (FMR) delivers controlled thermal injury via microneedles to stimulate collagen and elastin, with proposed benefits for skin texture and firmness. Facial muscle exercises (FME), or face yoga, aim to strengthen facial muscles, enhance tone, and lift sagging tissues. This single-center, outpatient, randomized, active-controlled, parallel-group trial enrolled 40 female participants aged ≥30 years with mild to moderate facial aging. Group A received an 8-week FME program (weekly online sessions plus daily home exercises). Group B underwent three FMR sessions using Vivace® device (non-insulated microneedles, 3.5 mm depth, 8 W, 600 ms pulse) at 4-week intervals. Primary outcomes were treatment success (≥25% improvement in PGAI) and patient satisfaction at Day 90. Secondary outcomes included MQCGS, WSRS, SGAIS, and improvement type (lifting versus texture). The study aimed to compare the two interventions across these outcome measures. Ethics approval was granted by the Research Ethics Committee, Faculty of Medicine, Cairo University; informed consent was obtained from all participants.

Interventions

BEHAVIORALFacial Muscle Exercise Program

Eight-week course with weekly online sessions and daily home exercises demonstrated via video. Exercises aimed to improve facial muscle tone and lifting effect.

DEVICEVivace® Fractional Microneedling Radiofrequency

Three sessions spaced 4 weeks apart; non-insulated microneedles; depth 3.5 mm; power 8 W; pulse 800 ms; pre-treatment topical anesthesia; post-treatment care with antibiotics and moisturizers.

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female participants aged ≥30 years * Mild to moderate facial aging (defined as grade 2-3 on Modified Quantitative Comprehensive Grading Scale of Aging and grade 2-4 on Wrinkle Severity Rating Scale) * Literate and able to follow instructions * Familiar with using online applications (e.g., Zoom) and have reliable internet access * Provided written informed consent for participation and photography

Exclusion criteria

* Age \<30 years * Severe facial aging (grade 4 on MQCGS and grade 5 on WSRS) * Current smoker * History of previous facelift surgery or thread lifting Botulinum toxin or filler injection within the past 12 months * Mesotherapy or topical rejuvenating therapy within the past 3 months * Body dysmorphic disorder * Medical history of autoimmune diseases, diabetes, or systemic conditions affecting healing * Pregnancy or lactation * Illiteracy or inability to follow instructions * Lack of internet access or inability to use online applications

Design outcomes

Primary

MeasureTime frameDescription
Treatment Success (≥25% improvement in Physician Global Aesthetic Improvement Score)Day 90 (End of Study)Proportion of participants achieving ≥25% improvement in PGAI compared to baseline.
Patient SatisfactionDay 90 (End of Study)Measured on a 3-point scale (0 = not satisfied, 1 = moderately satisfied, 2 = very satisfied).

Secondary

MeasureTime frameDescription
Modified Quantitative Comprehensive Grading Scale of Aging (MQCGS)Baseline, Day 30, Day 60, Day 90Change from baseline in Modified Quantitative Comprehensive Grading Scale of Aging (MQCGS) score. Scale range: 0-33 points, with higher scores indicating more severe facial aging (worse outcome).
Wrinkle Severity Rating Scale (WSRS)Baseline, Day 30, Day 60, Day 90Change from baseline in Wrinkle Severity Rating Scale (WSRS) score for nasolabial folds. Scale range: 1-5, with higher scores indicating more severe wrinkles (worse outcome).
Subject Global Aesthetic Improvement Score (SGAIS)Day 30, Day 60, Day 90Patient-reported improvement compared to baseline using Subject Global Aesthetic Improvement Score (SGAIS). Scale range: -1 to +3, with higher scores indicating greater improvement (better outcome). (-1 = worse, 0 = no change, +1 = improved, +2 = much improved, +3 = very much improved)
Improvement TypeDay 90Classification of improvement as lifting, texture, or both based on blinded dermatologist review.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026